Clickbait Science Exposed! Debunking the Mainstream Media's War on Cannabis

Clickbait Science Exposed! Debunking the Mainstream Media's War on Cannabis

Author: Cannabis Radio March 18, 2026 Duration: 22:57

Blunt Business tears apart the "bunk" science being weaponized by mainstream outlets like Reuters and The Guardian. By interrogating the raw data behind a widely cited Lancet Psychiatry study, the program exposes a collection of massive research failures—including tiny sample sizes, high risks of researcher bias, and a reliance on pharmaceutical synthetics that bear no resemblance to what consumers actually use.

We call out the "misinformation machine" funded by Big Pharma and shifts the focus to the real story: new evidence linking legalization to crime reduction and the definitive countdown to Virginia’s retail market launch in 2027.



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

There’s a lot more to the cannabis industry than what grows in the field. Blunt Business, from Cannabis Radio, digs into the complex reality of building and running a company in this fast-moving space. We’re talking about the real work behind the scenes-supply chain logistics, regulatory hurdles, branding in a crowded market, and managing teams in a unique cultural environment. Each episode brings together voices who are actually doing the job, from executives steering multi-state operations to entrepreneurs who just opened their first dispensary. You’ll hear candid roundtable discussions where strategies are debated, and interviews that get into the specifics of leadership and finance without the hype. This isn’t about advocacy or culture; it’s a practical look at the mechanics of a profitable, high-stakes business. Tune in for a podcast that cuts through the smoke and offers tangible insights you can apply, whether you’re an investor, a manager, or building your own venture from the ground up.
Author: Language: English Episodes: 100

Blunt Business
Podcast Episodes
A Psychedelic and Cannabis Research Revolution On the Horizon? [not-audio_url] [/not-audio_url]

Duration: 29:28
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental h…
4/20 Fortune: Critics Say High-Stakes Holiday Losing Its Edge? [not-audio_url] [/not-audio_url]

Duration: 24:45
As the legal landscape evolves, the traditional 4/20 retail boom is showing signs of cooling, with some markets seeing higher sales during the surrounding week than on the holiday itself due to aggressive discounting and…
Inside New York’s Five-Year Cannabis Chronicle [not-audio_url] [/not-audio_url]

Duration: 29:51
In this episode of The Blunt Business, the discussion dives deep into the complex landscape of the New York cannabis market as it hits its five-year legalization anniversary. While Governor Kathy Hochul lauds the state’s…
The Cannabis Business CLIMB or Cannabis for Healthy Livers [not-audio_url] [/not-audio_url]

Duration: 17:24
Blunt Business dives into the shifting landscape of American cannabis, from the halls of Congress to the microscopic world of medical research. We break down the newly proposed CLIMB Act, a bipartisan bill aimed at final…
How Rescheduling Could Transform Cannabis Economics and Brain Health [not-audio_url] [/not-audio_url]

Duration: 21:27
This week we explore the dual impact of cannabis legalisation and rescheduling—focusing on both the massive financial implications for the industry and emerging scientific research on health benefits.The $2 Billion Tax W…